DETERMINATION OF LEVELS OF IMMUNOGENIC GLUTEN PEPTIDES IN HUMAN SAMPLES

DETERMINATION OF LEVELS OF IMMUNOGENIC GLUTEN PEPTIDES IN HUMAN SAMPLES

The present invention relates to the medical/clinical sector and discloses a method for monitoring gluten ingestion by means of the measurement of gluten proteins/peptides in faeces using antibodies to immunogenic peptides resistant to gastrointestinal digestion. The presence or absence of said immu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: VIVAS ALEGRE, Santiago, COMINO MONTILLA, Isabel, CEBOLLA RAMÍREZ, Ángel, SOUSA MARTÍN, Carolina, REAL CALDERÓN, Ana
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator VIVAS ALEGRE, Santiago
COMINO MONTILLA, Isabel
CEBOLLA RAMÍREZ, Ángel
SOUSA MARTÍN, Carolina
REAL CALDERÓN, Ana
description The present invention relates to the medical/clinical sector and discloses a method for monitoring gluten ingestion by means of the measurement of gluten proteins/peptides in faeces using antibodies to immunogenic peptides resistant to gastrointestinal digestion. The presence or absence of said immunogenic peptides is monitored by means of immunological assays based on antibodies that react with immunogenic gluten peptides that are proteolysis-resistant. Said assays may be quantitative ELISA techniques, or qualitative assays such as rapid immunochromatographic assays, immunoblots, etc.; These measurements could also be used to verify adherence to a gluten-free diet with a view to enhancing diagnosis in cases of refractory or acute symptoms of coeliac disease in cases where a gluten-free diet is allegedly being complied with, or in the clinical investigation of the effectiveness of prolamine detoxification-related enzyme therapies..
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP2660593B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP2660593B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP2660593B13</originalsourceid><addsrcrecordid>eNrjZHB3cQ1xDfL19HMM8fT3U_B3U_BxDXP1CQaxPH19Q_383V39PJ0V3H1CQ1z9FAJcA0I8XVyDFTz9FDxCfR39FIIdfQN8XIN5GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4CRmZmBqaWxk6ExEUoAkQAsSw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DETERMINATION OF LEVELS OF IMMUNOGENIC GLUTEN PEPTIDES IN HUMAN SAMPLES</title><source>esp@cenet</source><creator>VIVAS ALEGRE, Santiago ; COMINO MONTILLA, Isabel ; CEBOLLA RAMÍREZ, Ángel ; SOUSA MARTÍN, Carolina ; REAL CALDERÓN, Ana</creator><creatorcontrib>VIVAS ALEGRE, Santiago ; COMINO MONTILLA, Isabel ; CEBOLLA RAMÍREZ, Ángel ; SOUSA MARTÍN, Carolina ; REAL CALDERÓN, Ana</creatorcontrib><description>The present invention relates to the medical/clinical sector and discloses a method for monitoring gluten ingestion by means of the measurement of gluten proteins/peptides in faeces using antibodies to immunogenic peptides resistant to gastrointestinal digestion. The presence or absence of said immunogenic peptides is monitored by means of immunological assays based on antibodies that react with immunogenic gluten peptides that are proteolysis-resistant. Said assays may be quantitative ELISA techniques, or qualitative assays such as rapid immunochromatographic assays, immunoblots, etc.; These measurements could also be used to verify adherence to a gluten-free diet with a view to enhancing diagnosis in cases of refractory or acute symptoms of coeliac disease in cases where a gluten-free diet is allegedly being complied with, or in the clinical investigation of the effectiveness of prolamine detoxification-related enzyme therapies..</description><language>eng ; fre ; ger</language><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; PHYSICS ; TESTING</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20181031&amp;DB=EPODOC&amp;CC=EP&amp;NR=2660593B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20181031&amp;DB=EPODOC&amp;CC=EP&amp;NR=2660593B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VIVAS ALEGRE, Santiago</creatorcontrib><creatorcontrib>COMINO MONTILLA, Isabel</creatorcontrib><creatorcontrib>CEBOLLA RAMÍREZ, Ángel</creatorcontrib><creatorcontrib>SOUSA MARTÍN, Carolina</creatorcontrib><creatorcontrib>REAL CALDERÓN, Ana</creatorcontrib><title>DETERMINATION OF LEVELS OF IMMUNOGENIC GLUTEN PEPTIDES IN HUMAN SAMPLES</title><description>The present invention relates to the medical/clinical sector and discloses a method for monitoring gluten ingestion by means of the measurement of gluten proteins/peptides in faeces using antibodies to immunogenic peptides resistant to gastrointestinal digestion. The presence or absence of said immunogenic peptides is monitored by means of immunological assays based on antibodies that react with immunogenic gluten peptides that are proteolysis-resistant. Said assays may be quantitative ELISA techniques, or qualitative assays such as rapid immunochromatographic assays, immunoblots, etc.; These measurements could also be used to verify adherence to a gluten-free diet with a view to enhancing diagnosis in cases of refractory or acute symptoms of coeliac disease in cases where a gluten-free diet is allegedly being complied with, or in the clinical investigation of the effectiveness of prolamine detoxification-related enzyme therapies..</description><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHB3cQ1xDfL19HMM8fT3U_B3U_BxDXP1CQaxPH19Q_383V39PJ0V3H1CQ1z9FAJcA0I8XVyDFTz9FDxCfR39FIIdfQN8XIN5GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4CRmZmBqaWxk6ExEUoAkQAsSw</recordid><startdate>20181031</startdate><enddate>20181031</enddate><creator>VIVAS ALEGRE, Santiago</creator><creator>COMINO MONTILLA, Isabel</creator><creator>CEBOLLA RAMÍREZ, Ángel</creator><creator>SOUSA MARTÍN, Carolina</creator><creator>REAL CALDERÓN, Ana</creator><scope>EVB</scope></search><sort><creationdate>20181031</creationdate><title>DETERMINATION OF LEVELS OF IMMUNOGENIC GLUTEN PEPTIDES IN HUMAN SAMPLES</title><author>VIVAS ALEGRE, Santiago ; COMINO MONTILLA, Isabel ; CEBOLLA RAMÍREZ, Ángel ; SOUSA MARTÍN, Carolina ; REAL CALDERÓN, Ana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP2660593B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2018</creationdate><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>VIVAS ALEGRE, Santiago</creatorcontrib><creatorcontrib>COMINO MONTILLA, Isabel</creatorcontrib><creatorcontrib>CEBOLLA RAMÍREZ, Ángel</creatorcontrib><creatorcontrib>SOUSA MARTÍN, Carolina</creatorcontrib><creatorcontrib>REAL CALDERÓN, Ana</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VIVAS ALEGRE, Santiago</au><au>COMINO MONTILLA, Isabel</au><au>CEBOLLA RAMÍREZ, Ángel</au><au>SOUSA MARTÍN, Carolina</au><au>REAL CALDERÓN, Ana</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DETERMINATION OF LEVELS OF IMMUNOGENIC GLUTEN PEPTIDES IN HUMAN SAMPLES</title><date>2018-10-31</date><risdate>2018</risdate><abstract>The present invention relates to the medical/clinical sector and discloses a method for monitoring gluten ingestion by means of the measurement of gluten proteins/peptides in faeces using antibodies to immunogenic peptides resistant to gastrointestinal digestion. The presence or absence of said immunogenic peptides is monitored by means of immunological assays based on antibodies that react with immunogenic gluten peptides that are proteolysis-resistant. Said assays may be quantitative ELISA techniques, or qualitative assays such as rapid immunochromatographic assays, immunoblots, etc.; These measurements could also be used to verify adherence to a gluten-free diet with a view to enhancing diagnosis in cases of refractory or acute symptoms of coeliac disease in cases where a gluten-free diet is allegedly being complied with, or in the clinical investigation of the effectiveness of prolamine detoxification-related enzyme therapies..</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP2660593B1
source esp@cenet
subjects INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
title DETERMINATION OF LEVELS OF IMMUNOGENIC GLUTEN PEPTIDES IN HUMAN SAMPLES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T07%3A16%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VIVAS%20ALEGRE,%20Santiago&rft.date=2018-10-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP2660593B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true